David Wilson Email & Phone Number

London, England, GB

Wetherby, England, GB

Avacta's Diagnostics Division, part of LSE AIM-listed Avacta Group plc (LSE:AVCT), develops and supplies a broad range of in-vitro diagnostic (IVD) solutions for healthcare professionals and consumers. The Division is growing rapidly through an M&A strategy to deliver a global scale IVD business providing market leading solutions for healthcare.

Wetherby, England, GB

Abercynon, GB

London, England, GB

London, GB

Birmingham, England, GB

Linear Diagnostics (LDL) was formed in 2013 as a spin-out of the University of Birmingham. LDL's platform technology utilises a combination of EXPAR and Linear Dichroism to provide rapid, accurate and cost-effective testing at the point-of-care. The Company has developed a duplex test for Chlamydia and Gonorrhea using a single-use, disposable cartridge.

York, Pennsylvania, US

Development and execution of international commercial strategy for medical device consumable portfolio entering global markets outside North America. Managing all aspects of market entry strategy including regulatory approvals and establishment and management of indirect sales channels, and delivery of revenue and gross margin targets.

London, GB

London, GB

Austin, Texas, US

Leading a team developing and delivering the commercial strategy for Asuragen's genetic and oncology molecular diagnostic product portfolio (PCR & NGS - based) in all global markets outside North America. Delivered >30% revenue growth in 12 months.Executive Committee - British In Vitro Diagnostics AssociationChair, Precision Diagnostics Working Party.

Austin, Texas, US

Led the development and execution of the commercial strategy for the EMEIA (EMEA + India) region for Asuragen's genetic and oncology diagnostic product portfolio. Delivered 25% revenue growth in 12 months.Executive Committee - British In Vitro DIagnostics AssociationChair, Precision Diagnostics Working Party - British In Vitro Diagnostics Association

Cambridge, Massachusetts, US

Led Alacrita's Dx consulting practice. Alacrita is a transatlantic partnership providing expertise-based consulting services to the pharmaceutical, biotechnology, diagnostics and life science industries. Chair, Precision Diagnostics Working Party at British In Vitro Diagnostics Association (BIVDA)Specialist research and advice to UK Trade and Investment.

Wayne, PA, US

Early commercial-stage molecular diagnostics company with a focus on the rapid, accurate detection of antibiotic resistant bacteria, including MRSA and other antibiotic resistant bacteria causing sepsis and gastrointestinal infectionsDeveloped, validated and implemented sales channel strategy in EMEAEstablished and ran subsidiary in Europe, which also.

Specialist IVD/medical device consultancy offering European market entry strategy development and implementation services, and commercial viability assessments of early-stage technologiesIdentified, selected and managed distributors in Europe for early-stage, US-based, IVD & medical device companies. Delivered first sales and sales growth for clients.

Paris, France, FR

Identified and evaluated investment opportunities (licensing and acquisitions) in European IVD markets, with a focus on innovative products and enabling technologies for quantitative point of care diagnostics.

Paris, France, FR

Management of the marketing function serving markets worldwide outside North and South America. Identifying and screening external product and technology opportunities deriving from countries outside the Americas.- Successfully launched three new products to international markets- Successfully led team that designed and implemented systems to enable CE.

Paris, France, FR

Sole representative in Europe for newly formed, NASDAQ-listed tracking stock. Responsible for generating revenues from sales of licenses and services based on proprietary genomics technology.

Paris, France, FR

Responsible for sales of manufactured raw materials and finished products to diagnostic companies in all global markets outside North and South America. - Delivered growth on an annual sales budget of $10m from all channels (OEM and distribution)- Exceeded sales target for newly introduced HDL cholesterol product by over $1m- Management of two Sales.

Paris, France, FR

Brighton, East Sussex, GB

Founding Director. SEHTA's Board of Directors comprises senior representatives from a cross-section of the health technologies industries based in the south east of England, including SMEs and global corporations. SEHTA was set up and funded by regional government to support the health technologies industries in the south east of England.

London, Greater London, GB

Registered as a PhD student at UCL, working under the supervision of Professor Avrion Mitchison (UCL) & Dr Joyce Taylor-Papadimitriou (Epithelial Biology Laboratory, Imperial Cancer Research Fund, Lincoln's Inn Fields Labs, London). Research published (see Publications).

Executive Education - Mergers And Acquisitions

Mba, Master Of Business Administration

Bsc (Hons), Biochemistry With Microbiology

2Nd Year Of Univ. St. Andrews Bsc Abroad, Biochemistry & Microbiology

Msc, Mathematical Finance And Trading (1St Year Only)